.
The articles in both columns
can be opened by clicking.
English webinar is at the bottom of Preface
中文视频在前言最下方
FDA LETTER TO DR. ZHANG RELATED TO MITOCHONDRIAL REPLACEMENT TECHNOLOGY*
Historical Bases of Hereditics:
Series of comments on mitochondrial replace therapy, stemcell and CRISPR for human reproduction. Quoted from ivf.net
*FDA sent letter to Dr. John Zhang on Aug. 4, 2017 to explain why MRT is prohibited in U.S. The key reason is:
"Since December 2015, the United States Food and Drug Administration (FDA) has been prohibited by Congress in provisions in annual federal Appropriations Acts from using funds to accept IND submissions for clinical investigations that involve “a human embryo . . . intentionally created or modified to include a heritable genetic modification.”
The letter declared that MRT and other subhuman reproduction will be prohibited forever in clinical practice forever, because MRT and other subhuman reproduction are neither scientific in Hereditics nor safe.
The letter was snapshot as the following:
